Gene · 3313
NIH grants1,948
NIH grants whose papers are about the gene, through NIH's grant-paper links.
681 to 700 of 1,948
Download this page as JSON| Grant | Title | HSPA9 papers | Newest fiscal year |
|---|---|---|---|
| R01CA207222 | Development of a novel therapeutic agent that exploits specific vulnerabilities in claudin low breast cancer | 1 | 2021 |
| R01CA207701 | Drugging the Undruggable Coactivators using Small Molecule Inhibitors | 1 | 2021 |
| R01CA210072 | Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts | 1 | 2021 |
| R01CA211861 | The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker | 1 | 2021 |
| R01CA213022 | Liver kinase B1 in angiogenesis | 1 | 2021 |
| R01CA213293 | Protein Arginine Methylation in Chemotherapy Resistance | 1 | 2021 |
| R01CA216242 | (PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer | 1 | 2021 |
| R01CA217182 | Targets of Reactive Lipid Species regulating DNA damage response and cell senescence | 1 | 2021 |
| R01CA218526 | High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer | 1 | 2021 |
| R01DK081418 | Thermogenic chromatin remodeling control and fat tissue communication | 1 | 2021 |
| R01DK118333 | Metabolic Link Between Peroxisomes and Mitochondria in the Regulation of Thermogenesis | 1 | 2021 |
| R01EY017950 | NEUROVASCULAR CROSS-TALK, FUNCTIONS AND SOURCES OF SOLUBLE VEGF RECEPTORS IN OCULAR VASCULAR DEMARCATION | 1 | 2021 |
| R01EY021862 | Regulation of Ocular Angiogenesis by microRNAs | 1 | 2021 |
| R01FD006029 | Natural History of Friedreich ataxia in children | 1 | 2021 |
| R01GM045443 | Stress Granules in Yeast and Mammals | 1 | 2021 |
| R01GM089820 | Gene Wiki: A community-maintained knowledge base of biomedical information | 1 | 2021 |
| R01GM100329 | Mechanisms of Archaeal Transcription Termination | 1 | 2021 |
| R01GM102365 | Combining systems biology and structural biology to find new therapeutics | 1 | 2021 |
| R01GM102413 | Post-translational regulation of DNA replication origin licensing in human cells | 1 | 2021 |
| R01GM102484 | Profiling and Dissecting the Dynamic Regulation of RNA Editing | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3313/grants?page=35